A pharmaceutical company is formulating a new medication that prevents painfulgout attacks. However, the lead researchers are also mindful of its impacts to thehuman liver, which can be indicated by monitoring levels of alanine aminotransferase(or ALT, in U/L units). If the ALT levels exceed an average of 55 U/L, there is anindication of the drug having damaging effects to the liver. Let us assume that ALTlevels are normally distributed with standard deviation of 15.7 U/L.To determine the consequence of this new drug, they randomly selected 162 adultmen with gout and monitored levels of alanine aminotransferase (or ALT, in U/Lunits) after taking the new medicine for 6 months.From the sample, it is found that the average ALT level is 59 U/L. It is suspectedlevels are significantly increased. Conduct a test of significance with a=0.05.What is your conclusion in the context of the problem?There is an indication of the new medication having damaging effects to thehuman liver as indicated by the significantly decreased ALT levels.There is an indication of the new medication having damaging effects to thehuman liver as indicated by the significantly increased ALT levels.There is no indication of the new medication having damaging effects to thehuman liver as indicated by a lack of sufficient evidence to support significantlydifferent ALT levels.At 95% level of significance, there is no indication of the new medication havingdamaging effects to the human liver.There is no indication of the new medication having damaging effects to thehuman liver as indicated by a lack of sufficient evidence to support significantlyincreased ALT levels.

Solution: Given information: n= 162 Sample size x=59 U/L Sample mean μ= 55 U/L Population mean σ=…

A pharmaceutical company is formulating a new medication that prevents painful gout attacks. However, the lead researchers are also mindful of its impacts to the human liver, which can be indicated by monitoring levels of alanine aminotransferase- (or ALT, in U/L units). If the ALT levels exceed an average of 55 U/L, there is an indication of the drug having damaging effects to the liver. Let us assume that ALT levels are normally distributed with standard deviation of 15.7 U/L. To determine the consequence of this new drug, they randomly selected 162 adult men with gout and monitored levels of alanine aminotransferase (or ALT, in U/L units) after taking the new medicine for 6 months. From the sample, it is found that the average ALT level is 59 U/L. It is suspected levels are significantly increased. Conduct a test of significance with a=0.05.

A pharmaceutical company is formulating a new medication that prevents painful gout attacks. However, the lead researchers are also mindful of its impacts to the human liver, which can be indicated by monitoring levels of alanine aminotransferase- (or ALT, in U/L units). If the ALT levels exceed an average of 55 U/L, there is an indication of the drug having damaging effects to the liver. Let us assume that ALT levels are normally distributed with standard deviation of 15.7 U/L. To determine the consequence of this new drug, they randomly selected 162 adult men with gout and monitored levels of alanine aminotransferase (or ALT, in U/L units) after taking the new medicine for 6 months. From the sample, it is found that the average ALT level is 59 U/L. It is suspected levels are significantly increased. Conduct a test of significance with a=0.05.

MATLAB: An Introduction with Applications

6th Edition

ISBN:9781119256830

Author:Amos Gilat

Publisher:Amos Gilat

Chapter1: Starting With Matlab

Section: Chapter Questions

Problem 1P

See similar textbooks

Similar questions

Please assist ASAP,a like is garanteed.
A research team is interested in investigating the effectiveness of a new medication intended to reduce resting heart rate (beats per minute, BPM) in overweight patients. In order to test the medication, the researcher organizes a clinical trial with participants randomly assigned to receive either the new medication or a placebo. Suppose the following table represents the heart rates for a SRS from both groups. Data for the placebo group are {71, 71, 68, 67, 68, 69, 70, 70, 69, 72, 73} Data for the treatment group are {67, 66, 64, 64, 65, 64, 59, 63, 71, 64} Sample standard deviation for the placebo group is: 1.834 Sample standard deviation for the treatment group is: 3.057 What is the confidence interval? (alpha=0.05) Group of answer choices (0.969492 to 9.266508) (2.31312 to 7.92288) (2.598132 to 7.637868) (-1.796934 to 12.032934)
In an area where there is no radioactive fallout, 1% of newborns show genetic disorders. Genetic disorders were observed in 150 out of 10000 babies born in a year in a region with radioactive fallout as a result of atomic bomb trials.Test whether radioactive fallout increases the rate of genetic defects at α = 0.05 significance level.
A research team is interested in investigating the effectiveness of a new medication intended to reduce resting heart rate (beats per minute, BPM) in overweight patients. In order to test the medication, the researcher organizes a clinical trial with participants randomly assigned to receive either the new medication or a placebo. Suppose the following table represents the heart rates for a SRS from both groups. Data for the placebo group are {71, 71, 68, 67, 68, 69, 70, 70, 69, 72, 73} Data for the treatment group are {67, 66, 64, 64, 65, 64, 59, 63, 71, 64} Sample standard deviation for the placebo group is: 1.834 Sample standard deviation for the treatment group is: 3.057 What is the Standard Error of the Mean Difference? (alpha=0.05) Group of answer choices 1.834 1.240 1.114 3.057
A research team is interested in investigating the effectiveness of a new medication intended to reduce resting heart rate (beats per minute, BPM) in overweight patients. In order to test the medication, the researcher organizes a clinical trial with participants randomly assigned to receive either the new medication or a placebo. Suppose the following table represents the heart rates for a SRS from both groups. Data for the placebo group are {71, 71, 68, 67, 68, 69, 70, 70, 69, 72, 73} Data for the treatment group are {67, 66, 64, 64, 65, 64, 59, 63, 71, 64} Sample standard deviation for the placebo group is: 1.834 Sample standard deviation for the treatment group is: 3.057 What is the test statistics (tstat)? (alpha=0.05) Group of answer choices 4.127 2.791 1.674 4.594
first picture is the background information
A group of 10-year-old boys were first ascertained in a camp for diabetic boys. They had their weight measured at baseline and again when they returned to camp 1 year later. Each time, a serum sample was obtained from which a determination of hemoglobin A1c (HgbA1c) was made. HgbA1c (also called glycosylated hemoglobin) is routinely used to monitor compliance with taking insulin injections. Usually, the poorer the compliance, the higher the HgbA1c level will be. The hypothesis is that the level HgbA1c is related to weight. The data in Table 11.28 were obtained. 11.95 Compute a rank correlation between change in weight and change in HgbA1c, each over 1 year. Use this measure to directly test the hypothesis that change in weight over 1 year is related to change in HgbA1c. Report a two-tailed p-value, and provide a 95% confidence interval for the underlying rank correlation.
first picture is the background information
A study is planned to investigate risk factors for sudden cardiac death. A cohort of men and women between the ages of 35 and 70 is enrolled and followed for up to 20 years. As part of the study, participants provide data on demographic and behavioral characteristics; they also undergo testing for cardiac function and provide blood samples to assess lipid profiles and other biomarkers. A new measure of inflammation is hypothesized to be related to sudden cardiac death. Describe its strengths and weaknesses.
first picture is the background information
why is the DV female drosophila Do you use a z or test for this problem?
We are researching the charity donation behaviour of Australians. We have the following model: (E1) Donate = β0 + β1Income +β2Avg_Gift + β3Edu + u Where: Donate is a dummy variable equal to 1 if the individual makes a donation in response to a social media campaign by our charity organisation, and 0 otherwise Income is the annual household income Avg_Gift is the average value of past donations made by the individual to our charity Educ is the individual's level of education (in years) Our data is a random sample of the population and we have 1,614 observations. You should assume E [u | Income, Avg_Gift, Educ] = 0. Using the information above, please answer the following 3 questions. [i] Referring to Model (E1) above, interpret the coefficient β1. [ii] You know that this model will suffer from heteroskedasticity. Why is this the case? Explain your reasoning. [iii] In your own words, what is heteroskedasticity?